SCRC Stock Could be Positioned for Snap-Back Rally Next Week
By: staff reporter, Melissa Diaz
Last Updated: April 10, 2015 8:05 AM EST
http://www.wallstreetnewscast.com/news/2015/0...-1624.html
(NEW YORK)--ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, may be setting up for a strong rally after a volatile week of price and volume.
SCRC stock experienced a sharp and steep drop earlier this week on stronger than normal volume. Following this event, a number of rumors swirled that there may be some sort of operational issue with their pharmaceutical business, or that a large note holder may had hit the exit button.
Following the sharp decline the Company issued a statement Thursday stating, 'ScripsAmerica (SCRC) knows of no reason relating to its operations that would account for the recent unusual volume and price activity in its stock. The Company has not provided any updates to the extensive discussion of the Company's business as presented in the Company's investor presentation as available on the Company's website, as well as other public disclosure that can be found on the website or filed with the SEC. Furthermore, the Company fully intends to reiterate all of the comments and disclosures at the upcoming 2nd Annual Growth Capital Expo in Las Vegas on Monday, April 13, 2015.'
This news helped alleviate fear that the sharp decline had been due to some operational issues, hence it is probably more likely related to some issue with a current note holder. If true, which remains to be seen, this could set SCRC up for possible sharp spike of recovery as the coming week could provide several catalysts that could increase wild swings within the stock.
Coming Events Next Week
As mentioned in their statement above, SCRC plans to present at the 2nd Annual Growth Capital Expo in Las Vegas this Monday, April 13, 2015. If the Company can show through public disclosure that no material changes were the cause for this weeks sharp drop, that could provide a real boast of confidence, which could spell for a very active start for the company trading week.
The next big event to occur next week that could spur a snap-back in the stock is their fiscal 2014 financial earnings. If the Company can show strong earnings growth, which is expected, and better yet provide that guidance remains strong for fiscal 2015, this weeks drop in share price could spell a spring time Christmas gift for traders.
Third Quarter 2014 Financial Results
The Company reported $12,817,000 in Net Revenue during the three months ended September 30, 2014 compared to $73,000 reported during the same period in 2013, marking an increase of $12,744,000 in quarterly revenue YoY. The Company's Net Revenue from operations during the nine months ended September 30, 2014 was reported as $17,342,000 compared to $452,000 over the same nine month period in 2013, marking an increase of $16,890,000 or 3,737%.
Gross profit for the three months ended September 30, 2014 was $11,604,000 compared to $43,000 for the same period in 2013, which is an increase of $11,561,000 or 26,886%. For the nine month period ended September 30, 2014, gross profit for the Company was approximately $15,525,343, which was 90% of its net sales as compared to a gross profit of approximately $27,783 for the same period in 2013 for an increase of approximately $15,497,560.
The Company's increase in gross profit from 2014 to 2013 can be attributed to its management of Main Avenue Pharmacy, which generated significant sales in the first nine months of 2014 and has a gross margin percentage ranging from 85% to 91%.
SCRC closed up 17% Thursday to a price of $0.078 per share, on volume of around 2.9 million shares traded.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com
To receive alerts on this and other stocks on the move enter your email address at top of page to join our investor email list
Safe Harbor Statements:
This research report includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
Disclaimer:
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast ("WSNC"
does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was not compensated for alert or media advisory services. WSNC, and its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments.
By: staff reporter, Melissa Diaz
Last Updated: April 10, 2015 8:05 AM EST
http://www.wallstreetnewscast.com/news/2015/0...-1624.html
(NEW YORK)--ScripsAmerica, Inc. (OTCBB:SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, may be setting up for a strong rally after a volatile week of price and volume.
SCRC stock experienced a sharp and steep drop earlier this week on stronger than normal volume. Following this event, a number of rumors swirled that there may be some sort of operational issue with their pharmaceutical business, or that a large note holder may had hit the exit button.
Following the sharp decline the Company issued a statement Thursday stating, 'ScripsAmerica (SCRC) knows of no reason relating to its operations that would account for the recent unusual volume and price activity in its stock. The Company has not provided any updates to the extensive discussion of the Company's business as presented in the Company's investor presentation as available on the Company's website, as well as other public disclosure that can be found on the website or filed with the SEC. Furthermore, the Company fully intends to reiterate all of the comments and disclosures at the upcoming 2nd Annual Growth Capital Expo in Las Vegas on Monday, April 13, 2015.'
This news helped alleviate fear that the sharp decline had been due to some operational issues, hence it is probably more likely related to some issue with a current note holder. If true, which remains to be seen, this could set SCRC up for possible sharp spike of recovery as the coming week could provide several catalysts that could increase wild swings within the stock.
Coming Events Next Week
As mentioned in their statement above, SCRC plans to present at the 2nd Annual Growth Capital Expo in Las Vegas this Monday, April 13, 2015. If the Company can show through public disclosure that no material changes were the cause for this weeks sharp drop, that could provide a real boast of confidence, which could spell for a very active start for the company trading week.
The next big event to occur next week that could spur a snap-back in the stock is their fiscal 2014 financial earnings. If the Company can show strong earnings growth, which is expected, and better yet provide that guidance remains strong for fiscal 2015, this weeks drop in share price could spell a spring time Christmas gift for traders.
Third Quarter 2014 Financial Results
The Company reported $12,817,000 in Net Revenue during the three months ended September 30, 2014 compared to $73,000 reported during the same period in 2013, marking an increase of $12,744,000 in quarterly revenue YoY. The Company's Net Revenue from operations during the nine months ended September 30, 2014 was reported as $17,342,000 compared to $452,000 over the same nine month period in 2013, marking an increase of $16,890,000 or 3,737%.
Gross profit for the three months ended September 30, 2014 was $11,604,000 compared to $43,000 for the same period in 2013, which is an increase of $11,561,000 or 26,886%. For the nine month period ended September 30, 2014, gross profit for the Company was approximately $15,525,343, which was 90% of its net sales as compared to a gross profit of approximately $27,783 for the same period in 2013 for an increase of approximately $15,497,560.
The Company's increase in gross profit from 2014 to 2013 can be attributed to its management of Main Avenue Pharmacy, which generated significant sales in the first nine months of 2014 and has a gross margin percentage ranging from 85% to 91%.
SCRC closed up 17% Thursday to a price of $0.078 per share, on volume of around 2.9 million shares traded.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com
To receive alerts on this and other stocks on the move enter your email address at top of page to join our investor email list
Safe Harbor Statements:
This research report includes statements that may constitute forward-looking statements made pursuant to the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although the Company believes that the expectations reflected in such forward-looking statements are based on reasonable assumptions, such statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected.
Disclaimer:
This is NOT a solicitation to Buy or Sell any security, but rather is for informational purposes only. Content contained herein includes facts, views, opinions and recommendations of individuals and organizations deemed of interest. Wall Street Newscast ("WSNC"
does not guarantee the accuracy, completeness or timeliness of, or otherwise endorse these views, opinions or recommendations, or give investment advice. WSNC, its affiliates, or directors, may or may not hold a position in the above security from time to time, and investors are encourage to consider this as a possible conflict of interest when reviewing this information. In Compliance with SEC Rule 17B Wall Street Newscast was not compensated for alert or media advisory services. WSNC, and its affiliates, may hold a position in above securities from time to time, and thus should be considered a possible conflict of interest when reviewing this report and information. These investments may involve a high degree of risk, thus investors are highly encouraged to consult with a financial advisor before any and all investments. 
